[Form 4] HeartBeam, Inc. Insider Trading Activity

Rhea-AI Filing Summary

HeartBeam, Inc. (BEAT) reporting person George de Urioste disclosed changes in beneficial ownership on 07/11/2025. The filing shows a disposition of 57,146 shares of common stock and a grant of 60,483 restricted stock units (RSUs) that vest 100% on the earlier of 07/11/2026 or the company's 2026 annual meeting, subject to continued service as an Outside Director. The report also lists a derivative position: a special option with a $1.65 exercise price covering 45,454 shares (total underlying common stock shown as 89,454 following the transactions). The RSUs do not expire; the option has exercise and vesting timing described in remarks.

Positive

• 60,483 RSUs granted that vest 100% by 07/11/2026, aligning director incentives with continued service
• Special option disclosed with a $1.65 exercise price and staged vesting, indicating equity retention mechanism

Negative

• 57,146 shares disposed (reported as a disposition), reducing immediate beneficial ownership
• Potential dilution from RSUs and options totaling 60,483 RSU rights and 45,454 option shares underlying common stock

Insights

Corporate Governance Expert

Insider received time‑based equity and disposed of existing shares; vesting ties retention to board service.

What it means: The reporting person was granted 60,483 RSUs that vest on 07/11/2026 or at the 2026 annual meeting if he remains an Outside Director, aligning compensation with continued board service.

Why it matters: Time‑based RSUs signal retention incentives for a director rather than immediate cash compensation. The disclosed 57,146 share disposition is a realized change in ownership that may affect short‑term share alignment but is explicitly recorded in the filing.

The filing also documents a special option with a $1.65 exercise price covering 45,454 shares with staged vesting; all terms are described in the form's remarks.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

de Urioste George

(Last) (First) (Middle)

2118 WALSH AVE, SUITE 210

(Street)

SANTA CLARA CA 95050

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HeartBeam, Inc. [ BEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								57,146	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Award	$0							(1)	(2)	Common Stock	60,483		60,483	D
Common Stock (right to buy)	$1.65							(3)	07/01/2035	Common Stock	45,454		89,454	D

Explanation of Responses:

1. These securities are restricted stock units (RSUs) granted on July 11, 2025. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 11, 2026, or the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.

2. RSUs do not expire, they either vest or are canceled prior to vesting date

3. Granted options on September 30, 2025, one half of the total number of Shares subject to the Special Option shall vest on the three-month anniversary of the vesting commencement date (July 1, 2025) and the remaining Shares shall vest on the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

Remarks:

	/s/ George de Urioste	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HeartBeam insider George de Urioste report on Form 4 (BEAT)?

The filing shows a disposition of 57,146 common shares, a grant of 60,483 restricted stock units (RSUs) vesting by 07/11/2026, and a special option covering 45,454 shares with a $1.65 exercise price.

When do the RSUs granted to the director vest?

The RSUs vest 100% on the earlier of July 11, 2026 or the date of the Issuer's 2026 annual meeting, subject to continuing service as an Outside Director.

Do the RSUs awarded to George de Urioste expire?

No. The filing states the RSUs do not expire; they either vest or are canceled prior to the vesting date.

What are the exercise terms of the option disclosed?

The special option has an exercise price of $1.65; vesting was described as half vesting three months and the remainder six months after a July 1, 2025 commencement date.

How many shares does the reporting person beneficially own after the transactions?

The filing shows 60,483 shares of common stock beneficially owned following the RSU grant and a derivative position reflecting 89,454 shares in total under certain entries.